Peanut Allergy Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Antihistamines is the fastest growing sector, North America is the largest market

The global market for peanut allergy treatments is projected to expand significantly, rising from USD 616.29 million in 2025 to USD 1.33 billion by 2031, demonstrating a compound annual growth rate of 13.69%. This market encompasses pharmaceutical products and immunotherapies, including oral and epicutaneous treatments, designed to desensitize individuals to peanut allergens and reduce the likelihood of severe anaphylactic responses.

Key growth factors for this market are the increasing worldwide incidence of IgE-mediated food allergies and considerable financial backing for clinical research and development programs focused on achieving long-term tolerance in both children and adults. Illustrating this dedication, the National Peanut Board reported an investment of over $38 million in 2025, specifically allocated to food allergy research and outreach efforts.

Market Drivers

A primary driver for the global peanut allergy treatment market is the escalating number of regulatory approvals for innovative therapeutics, which is significantly broadening patient eligibility and geographical access. Regulatory authorities are increasingly endorsing oral and epicutaneous immunotherapies, thereby paving the way for products aimed at younger patient groups where early intervention is crucial.

This trend enables manufacturers to address a critical unmet need in pediatric populations, who were previously confined to allergy avoidance strategies. For example, in January 2025, Stallergenes Greer announced European Commission approval for Palforzia's use in toddlers aged 1 to 3 with a confirmed diagnosis, expanding the market and stimulating further advancements in desensitization techniques.

Market Challenges

The global peanut allergy treatment market's expansion is notably limited by the safety concerns inherent in current immunotherapy protocols, particularly the possibility of anaphylaxis induced by treatment. These risks demand strict Risk Evaluation and Mitigation Strategies, requiring extended medical oversight during the initial phases of dose escalation.

This requirement places a considerable logistical strain on healthcare providers, as clinics must allocate specialized personnel and resources to monitor patients for severe reactions post-administration. This consequently creates a bottleneck in patient flow, restricting the number of individuals who can receive treatment concurrently and largely confining access to medical centers with ample resources.

Market Trends

A significant trend is the advancement of non-invasive epicutaneous immunotherapy patches, which involves substantial capital investment in late-stage clinical trials to confirm safety profiles distinct from systemic oral formulations. These patches utilize the skin's immune mechanisms to induce tolerance, differing from oral regimens that require ingestion, leading developers to maintain high operational expenditures to complete regulatory submissions.

The rigorous nature of this development phase is reflected in the financial reports of key patch developers; DBV Technologies, for instance, reported a net loss of $102.1 million in the third quarter of 2025, illustrating the considerable resources committed to progressing its Viaskin Peanut program through crucial testing stages.

Key Market Players

• Vedanta Biosciences, Inc.
• Alladapt Immunotherapeutics, Inc.
• Regeneron Pharmaceuticals Inc.
• Aravax Pty Ltd
• Teva Pharmaceutical Industries Limited
• Prota Therapeutics Pty Ltd.
• Aimmune Therapeutics, Inc.
• DBV Technologies SA
• Sanofi SA
• Mylan N.V.

Report Scope

In this report, the Global Peanut Allergy Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Peanut Allergy Treatment Market, by Drug Class:

• Antihistamines
• Epinephrine
• Immunotherapies
• Others

Peanut Allergy Treatment Market, by Route of Administration:

• Oral
• Intravenous
• Others

Peanut Allergy Treatment Market, by Distribution Channel:

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Peanut Allergy Treatment Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Peanut Allergy Treatment Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.